Germ-free C57BL/6J mice are resistant to high-fat-diet-induced insulin resistance and have altered cholesterol metabolism
- PMID:20724524
- DOI: 10.1096/fj.10-164921
Germ-free C57BL/6J mice are resistant to high-fat-diet-induced insulin resistance and have altered cholesterol metabolism
Abstract
Recent studies showed that germ-free (GF) mice are resistant to obesity when consuming a high-fat, high-carbohydrate Western diet. However, it remains unclear what mechanisms are involved in the antiobesity phenotype and whether GF mice develop insulin resistance and dyslipidemia with high-fat (HF) feeding. In the present study, we compared the metabolic consequences of HF feeding on GF and conventional (conv) C57BL/6J mice. GF mice consumed fewer calories, excreted more fecal lipids, and weighed significantly less than conv mice. GF/HF animals also showed enhanced insulin sensitivity with improved glucose tolerance, reduced fasting and nonfasting insulinemia, and increased phospho-Akt((Ser-473)) in adipose tissue. In association with enhanced insulin sensitivity, GF/HF mice had reduced plasma TNF-α and total serum amyloid A concentrations. Reduced hypercholesterolemia, a moderate accretion of hepatic cholesterol, and an increase in fecal cholesterol excretion suggest an altered cholesterol metabolism in GF/HF mice. Pronounced nucleus SREBP2 proteins and up-regulation of cholesterol biosynthesis genes indicate that enhanced cholesterol biosynthesis contributed to the cholesterol homeostasis in GF/HF mice. Our results demonstrate that fewer calorie consumption and increased lipid excretion contributed to the obesity-resistant phenotype of GF/HF mice and reveal that insulin sensitivity and cholesterol metabolism are metabolic targets influenced by the gut microbiota.
Similar articles
- Altered expression of transcription factors and genes regulating lipogenesis in liver and adipose tissue of mice with high fat diet-induced obesity and nonalcoholic fatty liver disease.Morgan K, Uyuni A, Nandgiri G, Mao L, Castaneda L, Kathirvel E, French SW, Morgan TR.Morgan K, et al.Eur J Gastroenterol Hepatol. 2008 Sep;20(9):843-54. doi: 10.1097/MEG.0b013e3282f9b203.Eur J Gastroenterol Hepatol. 2008.PMID:18794597
- Diet-genotype interactions in the early development of obesity and insulin resistance in mice with a genetic deficiency in tumor necrosis factor-alpha.Bouter B, Geary N, Langhans W, Asarian L.Bouter B, et al.Metabolism. 2010 Jul;59(7):1065-73. doi: 10.1016/j.metabol.2009.11.003. Epub 2009 Dec 31.Metabolism. 2010.PMID:20045154
- Dietary restriction of mice on a high-fat diet induces substrate efficiency and improves metabolic health.Duivenvoorde LP, van Schothorst EM, Bunschoten A, Keijer J.Duivenvoorde LP, et al.J Mol Endocrinol. 2011 Aug;47(1):81-97.J Mol Endocrinol. 2011.PMID:21830320
- Dietary fat and gut microbiota interactions determine diet-induced obesity in mice.Kübeck R, Bonet-Ripoll C, Hoffmann C, Walker A, Müller VM, Schüppel VL, Lagkouvardos I, Scholz B, Engel KH, Daniel H, Schmitt-Kopplin P, Haller D, Clavel T, Klingenspor M.Kübeck R, et al.Mol Metab. 2016 Oct 13;5(12):1162-1174. doi: 10.1016/j.molmet.2016.10.001. eCollection 2016 Dec.Mol Metab. 2016.PMID:27900259Free PMC article.
- Network analysis of hepatic genes responded to high-fat diet in C57BL/6J mice: nutrigenomics data mining from recent research findings.Kim EJ, Kim E, Kwon EY, Jang HS, Hur CG, Choi MS.Kim EJ, et al.J Med Food. 2010 Aug;13(4):743-56. doi: 10.1089/jmf.2009.1350.J Med Food. 2010.PMID:20553184Review.
Cited by
- The role of gut microbiota augmentation in managing non-alcoholic fatty liver disease: an in-depth umbrella review of meta-analyses with grade assessment.Maddineni G, Obulareddy SJ, Paladiya RD, Korsapati RR, Jain S, Jeanty H, Vikash F, Tummala NC, Shetty S, Ghazalgoo A, Mahapatro A, Polana V, Patel D.Maddineni G, et al.Ann Med Surg (Lond). 2024 Jun 20;86(8):4714-4731. doi: 10.1097/MS9.0000000000002276. eCollection 2024 Aug.Ann Med Surg (Lond). 2024.PMID:39118769Free PMC article.Review.
- The Intestinal Microbiota in Metabolic Disease.Woting A, Blaut M.Woting A, et al.Nutrients. 2016 Apr 6;8(4):202. doi: 10.3390/nu8040202.Nutrients. 2016.PMID:27058556Free PMC article.Review.
- Increased oral detection, but decreased intestinal signaling for fats in mice lacking gut microbiota.Duca FA, Swartz TD, Sakar Y, Covasa M.Duca FA, et al.PLoS One. 2012;7(6):e39748. doi: 10.1371/journal.pone.0039748. Epub 2012 Jun 29.PLoS One. 2012.PMID:22768116Free PMC article.
- Fortification and health: challenges and opportunities.Dwyer JT, Wiemer KL, Dary O, Keen CL, King JC, Miller KB, Philbert MA, Tarasuk V, Taylor CL, Gaine PC, Jarvis AB, Bailey RL.Dwyer JT, et al.Adv Nutr. 2015 Jan 15;6(1):124-31. doi: 10.3945/an.114.007443. Print 2015 Jan.Adv Nutr. 2015.PMID:25593151Free PMC article.Review.
- The Gut-Vascular Barrier as a New Protagonist in Intestinal and Extraintestinal Diseases.Di Tommaso N, Santopaolo F, Gasbarrini A, Ponziani FR.Di Tommaso N, et al.Int J Mol Sci. 2023 Jan 12;24(2):1470. doi: 10.3390/ijms24021470.Int J Mol Sci. 2023.PMID:36674986Free PMC article.Review.
Publication types
MeSH terms
Substances
Related information
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Research Materials
Miscellaneous